Are muscarinic agonists and acetylcholinesterase inhibitors effective for the treatment of underactive bladder? [PDF]
Introduction & Objectives: There are a range of mechanisms and systems underlying urinary bladder contractions, with interactions between nerves, endogenously released chemicals and receptors all playing a part in the overall function1,2.
Phelps, Charlotte; id_orcid +2 more
core +5 more sources
Central Nervous System-Active Medications and Risk of Hospital Readmission in Older Multimorbid Adults. [PDF]
ABSTRACT Background Polypharmacy is associated with adverse outcomes, particularly in older multimorbid adults. However, little is known about the negative outcomes associated with multiple central nervous system (CNS)‐active medications that are commonly prescribed to these patients. Objective To assess the association between the number of CNS‐active
Stuber MJ +10 more
europepmc +2 more sources
The secretory senescence in otorhinolaryngology: Principles of treatment [PDF]
Atrophy or hypofunction of the salivary gland because of aging, radiotherapy or disease causes hyposalivation and impairs the quality of life of patients by compromising mastication, swallowing and speech and by leading to a loss of taste.
Angeletti D. +20 more
core +3 more sources
Effects of Omidenepag Isopropyl Versus Latanoprost Eye Drops on Intraocular Pressure, Pupil Diameter, and Anterior Chamber Parameters in Normal Feline Eyes: A Pilot Study. [PDF]
ABSTRACT Objectives This study aimed to compare the effect of the newly developed selective prostaglandin E2 receptor agonist, omidenepag isopropyl (OMDI), and latanoprost on intraocular pressure (IOP), pupil diameter (PD), and anterior chamber parameters in normal feline eyes.
Park SE +5 more
europepmc +2 more sources
A Revised Model for Muscarine Biosynthesis Involving Lysine Trimethylation
The fatal mushroom toxin l‐(+)‐muscarine is one of the most prominent natural products. We elucidated its biosynthetic origin in the sweating mushroom Collybia rivulosa based on incorporation of stable isotope‐labeled compounds and extensive mass spectrometric analyses.
Sebastian Dörner +4 more
wiley +2 more sources
Autonomic drugs in the treatment of canine and feline glaucoma – Part I: Medications that lower intraocular pressure by increasing the outflow of aqueous humour [PDF]
One characteristic of the most common types of glaucoma is increased intraocular pressure (IOP), which has a damaging effect on optic nerve axons, leading to progressive loss of retinal ganglion cells. Therefore, ocular hypotensive drugs are the mainstay
Maslanka, T.
core +1 more source
Predictors of visual acuity, intraocular pressure and pain in neovascular glaucoma
Abstract Purpose To identify factors associated with best‐corrected visual acuity (BCVA), intraocular pressure (IOP) and ocular pain in neovascular glaucoma (NVG). Methods The retrospective cohort included all patients diagnosed with NVG during 2008–2024 at Helsinki University Hospital, Finland. Linear mixed‐effects models used pre‐specified covariates,
Gilbert Simons +5 more
wiley +1 more source
Abstract Purpose Analysing longitudinal trends in recorded diagnosis and medical management of glaucoma in Germany over a 10‐year period. Methods A retrospective cohort study using nationwide outpatient claims and prescription data from the German statutory health insurance system.
Somar M. Hasan +8 more
wiley +1 more source
Schematic illustration of the carbachol (CCH)–solid lipid nanoparticles (SLN) formulation, highlighting its structural design of experiments (DoE), physicochemical characterization, Hirshfeld surface analysis and pharmacokinetics predictions. ABSTRACT Carbachol (CCH) is a potent acetylcholine receptor agonist of hydrophilic and charged nature, which ...
Valentina Paganini +7 more
wiley +1 more source
Don't Sweat It: Cannabinoid CB1 Receptors Reduce Sweating in a Mouse Model
A new galvanic skin response‐based approach offers a simple method for measuring sweating in the paws of mice. This method is used to demonstrate that cannabinoid CB1 receptors reduce baseline sweating in mice, likely via inhibition of sympathetic acetylcholine release via axonal CB1 receptors.
Natalia Murataeva +3 more
wiley +1 more source

